Why Compare Loading and Maintenance Regimens?
A maintenance regimen supplies repeated doses intended to sustain exposure over time. Starting that regimen without a loading dose means concentration rises through accumulation, so early exposure may be lower than later exposure. A loading-plus-maintenance regimen gives an initial dose designed to reduce this delay. The practical question is not simply whether a loading dose raises concentration: it is how much earlier target exposure is reached, what additional early exposure results, and whether that benefit is consistent across the simulated population.
The comparison should follow the dosing histories that would actually be used. Simulate both regimens in the same virtual individuals, with the same parameter values and dosing schedule after initiation. Then compare prespecified early and later summaries, such as concentration at a chosen time, time above a target, or AUC over a defined window. Later profiles help show whether an initial difference persists or fades.
Deriving a Matched Loading Dose
First consider a one-compartment model with instantaneous intravenous bolus doses, linear elimination, constant apparent volume \(V\), and clearance \(CL\). Between doses, concentration declines exponentially with \(k_e=CL/V\). Suppose a maintenance dose \(D_M\) is given every \(\tau\) hours. Let \(C_{\max,ss}\) be the concentration just after a dose at steady state. The concentration just before the next dose is \(C_{\max,ss}e^{-k_e\tau}\); the next dose adds \(D_M/V\). Therefore, steady state requires
A single loading dose \(D_L\) at time zero produces an immediate concentration \(D_L/V\). To make this equal to the maintenance regimen’s steady-state peak, set \(D_L/V=C_{\max,ss}\). Thus:
This derivation gives a total loading dose for the stated model and timing: give \(D_L\) at time zero, then give maintenance doses at \(\tau,2\tau,\ldots\). The matching result is exact only under the assumptions used. For example, oral absorption, nonlinear elimination, time-varying clearance, or a different dose schedule can change the relationship. In an applied population simulation, calculate each regimen using the specified model rather than treating this equation as a universal dosing rule.
Worked Example: Matching a Loading Dose to a Steady-State Peak
Suppose a hypothetical adult has \(V=40\) L and \(CL=4\) L/h and receives \(D_M=200\) mg every \(\tau=12\) h by intravenous bolus. Find the loading dose that matches the maintenance regimen’s steady-state peak.
First, \(k_e=CL/V=4/40=0.1000\) h\(^{-1}\). Substitute into the loading-dose formula:
The immediate concentration after this dose is \(286.2/40=7.155\) mg/L. The maintenance-only steady-state peak is also \[ \frac{200/40}{1-e^{-1.2}}=7.155\ \text{mg/L}. \] The loading dose therefore matches the steady-state peak for this individual under the stated assumptions. It does not make concentration remain at 7.155 mg/L: concentration declines between doses, and the maintenance schedule is what replaces eliminated drug.
Early Exposure and Time to a Target
Consider a concentration target of 6.000 mg/L in the same hypothetical example. Under maintenance-only dosing, the first peak is \(200/40=5.000\) mg/L, below target. At 12 hours, the first dose has left \(5e^{-1.2}=1.506\) mg/L. The second 200 mg dose adds 5.000 mg/L, producing a peak of about 6.506 mg/L. Under loading-plus-maintenance, the first peak is 7.155 mg/L. For a bolus followed by exponential decline, the time from a peak \(C_{\max}\) to a lower target \(C_T\) is found by solving \(C_T=C_{\max}e^{-k_et}\):
This gives the duration above the target after a peak, provided the peak exceeds the target and the model describes the decline. It is not the same as the time until a target is first reached from below; with an instantaneous bolus, concentration jumps at dosing. For absorption models with a gradual rise, the first attainment time must instead be found from the simulated concentration-time profile.
Worked Example: Comparing Target Time During the First Day
Use the hypothetical \(V=40\) L, \(CL=4\) L/h, 200 mg every 12 hours regimen and target of 6.000 mg/L. Compare loading-plus-maintenance, with a 286.2 mg loading dose at time zero, against maintenance-only, which starts with 200 mg at time zero.
For loading-plus-maintenance, the initial peak is 7.155 mg/L. Its time above target before the first maintenance dose is
At 12 hours, the concentration from the loading dose has declined to approximately \(7.155e^{-1.2}=2.155\) mg/L. Adding the 200 mg maintenance dose raises the concentration to about 7.155 mg/L again; this peak is above target for a further 1.761 hours. Over the first 24 hours, the profile is therefore above target for about 3.522 hours, ignoring the instant of dosing as having zero duration.
For maintenance-only dosing, the first 5.000 mg/L peak is below target. At the second dose, the peak is approximately \(5+5e^{-1.2}=6.506\) mg/L. The time above target after that peak is
Thus, in this example, loading provides target-level concentrations earlier and about 3.522 hours above target in the first day, compared with about 0.810 hours for maintenance-only. These are model-based results for this individual and target, not population probabilities or a clinical recommendation.
AUC also distinguishes early regimens. In this linear bolus model, a dose \(D\) contributes \(D/CL\) to its complete concentration-time area. Over a finite window, only the area accrued within that window is counted. For the first 24 hours here, the loading regimen contributes the loading dose’s decay from time zero to 24 hours and the maintenance dose given at 12 hours over its first 12 hours:
Worked Example: Comparing First-Day AUC
For the loading regimen, \(CL=4\) L/h, so its first-day AUC is the sum of the two dose contributions:
For maintenance-only, the 200 mg dose at time zero contributes through 24 hours, and the 200 mg dose at 12 hours contributes through 12 hours:
The loading regimen therefore has about \(100.00-80.40=19.60\) mg·h/L more AUC during the first 24 hours. This is an early-window difference. With the same maintenance schedule thereafter, the concentration profiles move toward the same repeating steady-state profile under this linear model.
Population Simulation and Paired Comparisons
A typical-parameter calculation does not show how a regimen performs across individuals with different \(V\) and \(CL\). A population simulation should represent the intended covariate and parameter distributions, encode both dosing histories, and calculate the same early and later outcomes for each individual under both regimens. This paired comparison is informative because the difference for an individual is not obscured by comparing two unrelated samples of simulated subjects.
The following small hypothetical cohort illustrates the calculation. Each individual receives a fixed 286.2 mg loading dose or a 200 mg maintenance dose at time zero, followed by 200 mg every 12 hours in either regimen. The target is 6.000 mg/L. For this illustration, each individual follows the same one-compartment bolus model; only \(V\) and \(CL\) differ. The values at 1 hour use \(C(t)=C(0)e^{-k_et}\).
| Individual | V (L) | CL (L/h) | ke (h-1) | Loading regimen at 1 h (mg/L) | Maintenance-only at 1 h (mg/L) |
|---|---|---|---|---|---|
| A | 40 | 4.0 | 0.1000 | 6.474 | 4.524 |
| B | 30 | 3.0 | 0.1000 | 8.631 | 6.032 |
| C | 35 | 3.5 | 0.1000 | 7.399 | 5.171 |
| D | 45 | 3.6 | 0.0800 | 5.871 | 4.103 |
Worked Example: Comparing Target Attainment in a Small Virtual Cohort
For individual D, \(k_e=3.6/45=0.0800\) h\(^{-1}\). The loading-regimen concentration at time zero is \(286.2/45=6.360\) mg/L, so at 1 hour it is
The maintenance-only concentration at time zero is \(200/45=4.444\) mg/L, giving \(C_M(1)=4.444e^{-0.0800}=4.103\) mg/L. Applying the same calculation to all four individuals, three of four loading-regimen profiles are above 6.000 mg/L at 1 hour (A, B, and C), compared with one of four maintenance-only profiles (B). These fractions, 75% and 25%, describe only this four-person hypothetical cohort; they are not precise estimates of population attainment.
Diagnostics, Alternatives, and Limitations
Check that the dose history is implemented correctly: the loading dose occurs at the intended time, maintenance begins at the specified interval, and there is no accidental extra maintenance dose at time zero. Inspect concentration-time profiles for representative individuals and verify that concentrations decline or accumulate in ways consistent with the model. Also verify units: \(CL/V\) has units of inverse time, concentration has units of amount per volume, and AUC has units of concentration multiplied by time.
The key comparison is the regimen contrast, not merely whether either regimen meets a target in isolation. A typical-parameter deterministic profile is useful for checking arithmetic and illustrating mechanism, but a virtual-cohort simulation describes heterogeneity. A matched loading dose calculated separately for every individual is another useful theoretical benchmark, but it assumes access to each individual’s true parameters and is generally not a feasible fixed regimen. A fixed loading dose based on typical values is more realistic in many simulations, but may overshoot or undershoot for individuals whose parameters differ.
In the linear model, a matched loading dose places the initial peak at the corresponding steady-state peak. The discrepancy between a maintenance-only profile and its steady-state profile decreases with elapsed time because the contribution from the initial condition decays exponentially. For two regimens with the same subsequent maintenance doses, this supports comparing both the early window, when loading can matter, and a later window, when the initial-dose difference may have diminished.
Several limitations remain. A one-compartment bolus model does not capture absorption delay, distribution phases, nonlinear clearance, or time-varying physiology. A single concentration target may not represent the exposure measure relevant to treatment, and matching a peak does not necessarily match AUC or time above a target. Population results also depend on whether the simulated parameter distributions and covariate relationships are credible. Report the regimen, target, time window, model assumptions, and population summary together so that a simulated advantage is not mistaken for a universal clinical effect.
Specify loading and maintenance doses, administration times, target, and early and later evaluation windows.
Use the same virtual individuals, parameter values, and model assumptions for both regimens.
Compare early concentrations, target duration or attainment, and later exposure using clearly stated units and windows.
Inspect dose timing, representative profiles, units, and the extent to which conclusions depend on model assumptions.
Check Your Understanding
Answer each question, then compare your reasoning with the solutions.
- For \(D_M=150\) mg, \(k_e=0.0800\) h\(^{-1}\), and \(\tau=12\) h, calculate the loading dose that matches the steady-state peak.
- In the hypothetical \(V=40\) L, \(CL=4\) L/h example, why does reaching 6 mg/L at time zero under loading not mean concentration stays above 6 mg/L?
- What is the maintenance-only second peak for 200 mg every 12 hours with \(V=40\) L and \(CL=4\) L/h?
- Why should the same simulated individuals be used to compare both regimens?
Solutions. (1) Use \(D_L=D_M/(1-e^{-k_e\tau})\): \(150/[1-e^{-0.0800(12)}]=150/(1-0.3829)=243.1\) mg. (2) Between bolus doses, concentration declines exponentially. From 7.155 mg/L, it falls to 6.000 mg/L after \(\ln(7.155/6.000)/0.1000=1.761\) hours, then is below target until a later dose raises it. (3) The first 5.000 mg/L peak declines to \(5e^{-1.2}=1.506\) mg/L by 12 hours; the second dose adds 5.000 mg/L, giving \(1.506+5.000=6.506\) mg/L. (4) Paired simulation holds each individual’s parameters fixed across regimens, so the contrast reflects the dosing strategy rather than differences in the composition of two independently sampled cohorts.